AVTR Avantor, Inc. Common Stock
NYSE · Life Sciences Tools & Services · SEC EDGAR で表示 ↗ 終値 10月 2, 2026 10-K/10-Q 7月 29, 2026
$15.34
· 52週範囲の%
· 安値より上
· 高値へ
$7.2752週安値
$16.0552週高値
時価総額
$10.46B
P/E (TTM)
-18.3
EPS (TTM)
$-0.84
収益 (TTM)
$6.56B
あなたのバッジ
52週レンジ
$7–$16
アナリスト評価
HOLD
目標株価
$15
P/E
-18.3
ROE
-9.7%
純利益率
-8.8%
バッジストリップは空です。このページ上の任意の指標をピン留めしてください。
AVTR 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
株価
$15.34
時価総額
$10.46B
P/E (TTM)
-18.3
EPS (TTM)
$-0.84
収益 (TTM)
$6.56B
ROE (TTM)
-9.7%
負債/自己資本 (MRQ)
0.7
52週レンジ
$7–$16
AVTR 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
範囲
バー
バーの粒度は選択した期間に合わせて調整されます。バーの始値/高値/安値/終値を確認するにはチャートにカーソルを合わせてください。
Avantor, Inc. Common Stock について Wikipediaからの企業概要
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.
History
The company's history traces back to 1904, when John Townsend Baker (1860–1935) founded the chemical company J.T. Baker specializing in producing chemically pure reagents. The company gained recognition for its "Baker Analyzed" labels, which provided detailed analyses of trace impurities in its products. In 1911, the company began publishing "The Chemist-Analyst," which promoted its products and philosophy. After Baker's death in 1935, the company was acquired by Vick Chemical Company in 1941. During World War II, J.T. Baker expanded its product line to include penicillin, pesticides, and chemicals for batteries and munitions. After the war, the company further diversified into high-purity solvents, chromatography columns, and hazardous waste spill kits. In 1985, J.T. Baker and its parent company Richardson-Vicks were sold to Procter & Gamble, and subsequently sold to Mallinckrodt in 1995.
In 2010, investment firm New Mountain Capital purchased Mallinckrodt Baker Inc., which then changed its name to Avantor. The company extended its international market with the 2011 acquisitions of the Indian laboratory reagents supplier RFCL and the Polish lab supply firm POCH.
In 2016, Avantor merged with Nusil Technology. In 2017, Avantor acquired chemical blending business Puritan Products Inc. and laboratory supplies company VWR. The combined company operates under the Avantor name, with VWR and vwr.com remaining as a selling channel.
In May 2019, Avantor went public with a $3.8 billion initial public offering, which gave the company a market capitalization of $7.62 billion. As of December 2023, the top shareholders of Avantor included Vanguard Group Inc., Dodge & Cox Inc., T. Rowe Price Investment Management Inc., and BlackRock Inc.
That same year the company expanded further into Asia with the opening of an innovation center in Shanghai, which focuses on monoclonal antibodies and cell and gene therapy. In 2020, Avantor doubled the size of its Bridgewater, New Jersey innovation center, expanding its research and development capabilities and cell and gene therapy reagent manufacturing.
In 2020, Avantor began providing services and raw materials to companies manufacturing vaccines and other therapies to fight the COVID-19 pandemic. Avantor added employees and extra shifts in order to increase capacity for producing synthetic lipids that are formed into nanoparticles, which carry mRNA into human cells.
In June 2021, Avantor acquired China-based RIM Bio, a manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.
Through the acquisition, Avantor gained access to RIM's Changzhou, China facility, marking Avantor's first single-use production plant in the Africa, Middle East, Asia (AMEA) region. The deal is part of a larger expansion of the company's single-use manufacturing footprint with plans to increase its presence by 30%.
The company ranked 485th in 2023 and 506 in 2024 on the Fortune 500, based on its sales records.
Controversies
On August 26, 2020, Bloomberg News implicated Avantor and other companies in the U.S. opioid epidemic. According to Bloomberg, one of their compounds "acetic anhydride", was used illicitly by drug traffickers to convert crude opium into heroin. Bloomberg also found evidence that Avantor's compound was used in cartel drug labs, and that regulations implemented in 2018 didn't stop it from being widely available. In response, Avantor discontinued all sales of acetic anhydride in Mexico and destroyed its existing inventory. In 2021, Texas Senator John Cornyn, who serves on both the Judiciary Committee and the bipartisan Caucus on International Narcotics Control claims that Avantor should have known better, selling acetic anhydride within Mexico's unregulated market. What should have raised eyebrows as well is that it was sold in 18-liter containers, which is inconsistent with the ordinary use of acetic anhydride. Four other Republican senators also deplored Avantor's “apparent longstanding contribution to the opioid epidemic that killed 50,000 of our fellow citizens in 2019.”
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
セクターHealthcare
業種Life Sciences Tools & Services
従業員13,500
国US
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
収益$6.55B2017-12-31 → 2025-12-31
EPS$-0.782018-12-31 → 2025-12-31
フリーキャッシュフロー$495M2019-12-31 → 2025-12-31
純利益率-8.8%2019-12-31 → 2025-12-31
バリュエーションと指標
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
| 指標 | 5年トレンド | AVTR | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| P/E (TTM) | -18.35年平均 ≈24.9 | ≈24.9 | · | · | |
| P/S | 1.65年平均 ≈2.2 | ≈2.2 | 3.7 | 割安 | |
| P/B (株価純資産倍率) | 1.95年平均 ≈3.2 | ≈3.2 | 3.6 | 割安 | |
| EV / EBITDA (EV/EBITDA) | -57.05年平均 ≈10.3 | ≈10.3 | · | · | |
| Price / FCF (株価FCF倍率) | 21.15年平均 ≈21.7 | ≈21.7 | · | · | |
| Price / Cash Flow (株価収益率（P/CF）) | 16.85年平均 ≈18.2 | ≈18.2 | 25.2 | 割安 | |
| EV / Revenue (EV/売上高) | 2.15年平均 ≈2.9 | ≈2.9 | · | · | |
| EV / FCF (EV/FCF) | 28.45年平均 ≈28.9 | ≈28.9 | · | · |
同業他社の中央値は、指標ごとに標準化された基準で計算されており、この銘柄に表示されているTTM/MRQ基準と常に一致するとは限りません。
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
| 指標 | 5年トレンド | AVTR | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| 粗利益率 (TTM) | 31.8%5年平均 ≈33.7% | ≈33.7% | 54.2% | 弱い | |
| 営業利益率 (TTM) | -4.6%5年平均 ≈10.1% | ≈10.1% | 9.2% | 平均以下 | |
| EBITDA Margin (EBITDAマージン) | -3.8%5年平均 ≈10.1% | ≈10.1% | 8.3% | 弱い | |
| 税引前利益率 (TTM) | -7.2%5年平均 ≈6.7% | ≈6.7% | 5.9% | 平均以下 | |
| 純利益率 (TTM) | -8.8%5年平均 ≈4.8% | ≈4.8% | 2.4% | 同水準 | |
| ROA (TTM) | -4.7%5年平均 ≈2.7% | ≈2.7% | -0.14% | 弱い | |
| ROE (TTM) | -9.7%5年平均 ≈7.6% | ≈7.6% | -0.40% | 弱い | |
| ROIC | -3.1%5年平均 ≈5.1% | ≈5.1% | 1.1% | 弱い |
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
| 指標 | 5年トレンド | AVTR | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| 負債資本倍率 (MRQ) | 0.75年平均 ≈1.1 | ≈1.1 | 0.7 | 同水準 | |
| 流動比率 (MRQ) | 1.85年平均 ≈1.6 | ≈1.6 | 3.0 | 低流動性 | |
| Quick Ratio (クイックレシオ) | 1.05年平均 ≈0.9 | ≈0.9 | 1.6 | 平均以下 | |
| 長期負債/株主資本 (MRQ) | 0.75年平均 ≈1.0 | ≈1.0 | 0.7 | 同水準 |
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
| 指標 | 5年トレンド | AVTR | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| Revenue YoY (収益（前年比）) | -3.4%5年平均 ≈0.78% | ≈0.78% | · | · | |
| Revenue CAGR 3Y (収益（3年CAGR）) | -4.5%5年平均 ≈-1.4% | ≈-1.4% | · | · | |
| Revenue CAGR 5Y (収益（5年CAGR）) | 0.49% | · | · | · | |
| EPS YoY | 121.3%5年平均 ≈232.8% | ≈232.8% | · | · | |
| Net Income YoY (純利益（前年比）) | 121.6%5年平均 ≈119.8% | ≈119.8% | · | · | |
| EPS CAGR 3Y (EPS年平均成長率 3年) | 7.0% | · | · | · | |
| Net Income CAGR 3Y (純利益年平均成長率 3年) | 7.5% | · | · | · |
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
| 指標 | 5年トレンド | AVTR | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| Asset Turnover (総資産回転率) | 0.55年平均 ≈0.6 | ≈0.6 | 0.5 | 同水準 | |
| Inventory Turnover (棚卸資産回転率) | 5.75年平均 ≈5.7 | ≈5.7 | 2.5 | トップクラス | |
| Receivables Turnover (売掛金回転率) | 6.25年平均 ≈6.2 | ≈6.2 | 5.7 | トップクラス | |
| Revenue / Employee (年間売上高 ÷ 従業員数（yfinanceの報告ヘッドカウント）。派生値 — SEC-XBRLの保存概念ではありません。) | ≈$485.3K | · | · | · |
バリュエーション · ≈ 5年平均 · 業界中央値 · 中央値に対する評価
決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
平均サプライズ
0.49%
次回決算
10月 27, 2026
| 期間 | レポート | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|---|
| 2026年6月30日 | 7月 30, 2026 | $0.21 | $0.19 | 8.6% |
| 2026年3月31日 | $0.17 | $0.16 | 6.2% | |
| 2025年12月31日 | $0.22 | $0.22 | -0.36% | |
| 2025年9月30日 | $0.22 | $0.23 | -4.0% | |
| 2025年6月30日 | $0.24 | $0.25 | -5.1% | |
| 2025年3月31日 | $0.23 | $0.24 | -2.4% |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B | $6.39B | $6.04B | $5.86B | $1.25B | |
| Cost of Revenue | $4.41B | $4.50B | $4.60B | $4.91B | $4.88B | $4.31B | $4.12B | $4.04B | $815M | |
| Gross Profit | $2.14B | $2.28B | $2.36B | $2.60B | $2.50B | $2.08B | $1.92B | $1.82B | $433M | |
| SG&A Expense | $1.60B | $1.64B | $1.51B | $1.47B | $1.53B | $1.37B | $1.37B | $1.41B | $450M | |
| Operating Income | $-246M | $1.08B | $696M | $1.13B | $972M | $707M | $552M | $414M | $-210M | |
| Interest Expense | · | · | $285M | $266M | $217M | $308M | $440M | $524M | $201M | |
| Interest Income | $42M | $75M | $65M | $16M | $2M | · | · | · | · | |
| Other Non-op | $-21M | $-1M | $6M | $-800.0K | $11M | $10M | $2M | $-4M | $8M | |
| Pretax Income | $-441M | $854M | $410M | $851M | $753M | $62M | $41M | $-114M | $-460M | |
| Income Tax | $89M | $142M | $89M | $165M | $180M | $-54M | $3M | $-27M | $-315M | |
| Net Income | $-530M | $712M | $321M | $686M | $573M | $117M | $38M | $-87M | $-113M | |
| EPS (Basic) | $-0.78 | $1.05 | $0.48 | $1.02 | $0.86 | $0.09 | $-0.84 | $-2.69 | · | |
| EPS (Diluted) | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 | $0.09 | $-0.84 | $-2.69 | · | |
| Shares (Basic) | 680,600,000 | 679,600,000 | 675,600,000 | 650,900,000 | 590,500,000 | 576,300,000 | 401,200,000 | 132,700,000 | · | |
| Shares (Diluted) | 680,600,000 | 681,900,000 | 678,400,000 | 679,400,000 | 599,600,000 | 583,400,000 | 401,200,000 | 132,700,000 | · | |
| EBITDA | $-246M | $1.08B | $696M | $1.13B | $972M | $707M | $552M | · | · |
貸借対照表
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $365M | $262M | $263M | $373M | $302M | $287M | $187M | $185M | · | |
| Receivables | $1.07B | $1.03B | $1.15B | $1.22B | $1.22B | $1.11B | $989M | $931M | · | |
| Inventory | $818M | $732M | $828M | $914M | $872M | $740M | $711M | $671M | · | |
| Other Current Assets | $193M | $119M | $144M | $153M | $81M | $91M | $135M | $113M | · | |
| Current Assets | $2.45B | $2.15B | $2.38B | $2.66B | $2.48B | $2.23B | $2.02B | $1.90B | · | |
| PP&E (Net) | $767M | $708M | $738M | $727M | $706M | $550M | $557M | $599M | · | |
| PP&E (Gross) | $1.51B | $1.34B | $1.35B | $1.25B | $1.15B | $938M | $865M | $824M | · | |
| Accum. Depreciation | $745M | $630M | $617M | $518M | $445M | $388M | $308M | $226M | · | |
| Goodwill | $4.99B | $5.54B | $5.72B | $5.65B | $5.34B | $2.86B | $2.77B | $2.78B | $2.85B | |
| Intangibles | $3.10B | $3.27B | $3.68B | $4.04B | $5.05B | $3.96B | $4.13B | $4.47B | · | |
| Other Non-current Assets | $396M | $360M | $358M | $294M | $233M | $217M | $205M | $63M | · | |
| Total Assets | $11.79B | $12.11B | $12.97B | $13.46B | $13.90B | $9.91B | $9.77B | $9.91B | · | |
| Accounts Payable | $742M | $663M | $626M | $758M | $755M | $679M | $560M | $557M | · | |
| Current Liabilities | $1.38B | $2.01B | $1.48B | $1.66B | $1.45B | $1.24B | $1.07B | $1.10B | · | |
| Capital Leases | $152M | $143M | $88M | $87M | $79M | · | $107M | · | · | |
| Deferred Tax | $557M | $557M | $613M | $731M | $913M | $724M | $785M | $908M | · | |
| Other Non-current Liabilities | $378M | $358M | $350M | $295M | $358M | $398M | $428M | $318M | · | |
| Total Liabilities | $6.23B | $6.16B | $7.72B | $8.61B | $9.70B | $7.23B | $7.31B | $9.10B | · | |
| Long-term Debt | $3.95B | $4.06B | $5.54B | $6.29B | $7.02B | $4.89B | $5.12B | $6.92B | · | |
| Total Debt | $3.95B | $4.06B | $5.54B | $6.29B | $7.02B | $4.89B | $5.12B | · | · | |
| Retained Earnings | $1.67B | $2.20B | $1.49B | $1.17B | $484M | $-89M | $-204M | $-238M | · | |
| Treasury Stock | $76M | $0 | · | · | · | · | · | · | · | |
| AOCI | $-17M | $-184M | $-69M | $-100M | $-43M | $22M | $-86M | $-66M | $26M | |
| Stockholders' Equity | $5.57B | $5.96B | $5.25B | $4.86B | $4.20B | $2.67B | $2.46B | $-3.05B | $-2.62B | |
| Liabilities + Equity | $11.79B | $12.11B | $12.97B | $13.46B | $13.90B | $9.91B | $9.77B | $9.91B | · | |
| Shares Outstanding | 682,000,000 | 680,800,000 | 676,600,000 | 674,300,000 | 609,700,000 | 580,100,000 | 572,800,000 | 132,800,000 | · |
キャッシュフロー
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $410M | $406M | $402M | $406M | $379M | $395M | $399M | $405M | $99M | |
| Stock-based Comp | $46M | $47M | $40M | $46M | $51M | $44M | $68M | $18M | $48M | |
| Deferred Tax | $8M | $-47M | $-172M | $-69M | $-18M | $-88M | $-107M | $-104M | $-431M | |
| Amort. of Intangibles | $301M | $300M | $308M | $318M | $291M | $308M | $312M | $321M | $65M | |
| Restructuring | $30M | $83M | $26M | $4M | $5M | $12M | $24M | $81M | $30M | |
| Operating Cash Flow | $624M | $841M | $870M | $844M | $954M | $930M | $354M | $200M | $-168M | |
| CapEx | $129M | $149M | $146M | $133M | $111M | $62M | $52M | $38M | $25M | |
| Investing Cash Flow | $-130M | $439M | $-144M | $-110M | $-4.12B | $-59M | $-42M | $-23M | $-6.68B | |
| Debt Issued | $1.11B | $0 | $0 | $327M | $2.83B | $3.94B | $1M | $36M | $9.25B | |
| Net Debt Issued | $-319M | $-1.34B | $-846M | $-620M | $2.30B | $-423M | $-1.88B | · | · | |
| Stock Issued | · | · | $0 | $0 | $967M | $0 | $4.24B | · | · | |
| Stock Repurchased | $75M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $-75M | · | $0 | $0 | $967M | · | · | · | · | |
| Financing Cash Flow | $-409M | $-1.28B | $-844M | $-649M | $3.22B | $-783M | $-308M | $-170M | $6.96B | |
| Net Change in Cash | $104M | $-23M | $-109M | $70M | $38M | $100M | $2M | $-800.0K | $122M | |
| Taxes Paid | $145M | $248M | $224M | $257M | $145M | $43M | $112M | $66M | $32M | |
| Free Cash Flow | $495M | $692M | $724M | $710M | $842M | $868M | $302M | · | · | |
| Levered FCF | · | · | $501M | $496M | $677M | $292M | $-107M | · | · |
収益性
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.6% | 33.6% | 33.9% | 34.6% | 33.9% | 32.5% | 31.8% | · | · | |
| Operating Margin | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% | 11.1% | 9.1% | · | · | |
| Net Margin | -8.1% | 10.5% | 4.6% | 9.1% | 7.8% | 1.8% | 0.63% | · | · | |
| Pretax Margin | -6.7% | 12.6% | 5.9% | 11.3% | 10.2% | 0.97% | 0.67% | · | · | |
| EBITDA Margin | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% | 11.1% | 9.1% | · | · | |
| ROA | -4.4% | 5.7% | 2.4% | 5.0% | 4.8% | 1.2% | 0.38% | · | · | |
| ROE | -8.9% | 12.4% | 6.2% | 14.5% | 13.8% | 4.5% | 1.6% | · | · | |
| ROIC | -3.1% | 9.0% | 5.1% | 8.2% | 6.6% | 17.5% | 6.8% | · | · |
流動性と支払能力
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.1 | 1.6 | 1.6 | 1.7 | 1.8 | 1.9 | · | · | |
| Quick Ratio | 1.0 | 0.6 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | · | · | |
| Debt / Equity | 0.7 | 0.7 | 1.1 | 1.3 | 1.7 | 1.8 | 2.1 | · | · | |
| LT Debt / Equity | 0.7 | 0.5 | 1.0 | 1.2 | 1.7 | 1.8 | 2.0 | · | · | |
| Interest Coverage | · | · | 2.4 | 4.3 | 4.5 | 2.3 | 1.3 | · | · |
効率性
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | · | · | |
| Inventory Turnover | 5.7 | 5.8 | 5.3 | 5.5 | 6.1 | 5.9 | 6.0 | · | · | |
| Receivables Turnover | 6.2 | 6.2 | 5.9 | 6.2 | 6.3 | 6.1 | 6.3 | · | · |
1株あたり
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.16 | $8.75 | $7.76 | $7.20 | $6.88 | $4.61 | $4.30 | · | · | |
| Revenue / Share | $9.63 | $9.95 | $10.27 | $11.06 | $12.32 | $10.96 | · | · | · | |
| Cash Flow / Share | $0.92 | $1.23 | $1.28 | $1.24 | $1.59 | $1.59 | · | · | · | |
| Cash / Share | $0.54 | $0.38 | $0.39 | $0.55 | $0.49 | $0.49 | $0.33 | · | · | |
| EPS (TTM) | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 | $0.09 | $-0.84 | · | · |
成長率
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -3.4% | -2.6% | -7.3% | 1.7% | 15.5% | · | · | · | · | |
| Revenue CAGR 3Y | -4.5% | -2.8% | 2.9% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.49% | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 121.3% | -53.5% | 18.8% | 844.4% | · | · | · | · | |
| EPS CAGR 3Y | · | 7.0% | 73.5% | · | · | · | · | · | · | |
| Net Income YoY | · | 121.6% | -53.2% | 19.9% | 391.1% | · | · | · | · | |
| Net Income CAGR 3Y | · | 7.5% | 40.2% | · | · | · | · | · | · |
バリュエーション（TTM）
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B | $6.39B | $6.04B | · | · | |
| Net Income TTM | $-530M | $712M | $321M | $686M | $573M | $117M | $38M | · | · | |
| Market Cap | $7.82B | $14.34B | $15.45B | $14.22B | $25.69B | $16.33B | $10.40B | · | · | |
| Enterprise Value | $11.40B | $18.14B | $20.72B | $20.14B | $32.41B | $20.94B | $15.33B | · | · | |
| P/E | -14.7 | 20.3 | 48.6 | 20.9 | 49.6 | 312.8 | -21.6 | · | · | |
| P/S | 1.2 | 2.1 | 2.2 | 1.9 | 3.5 | 2.6 | 1.7 | · | · | |
| P/B | 1.4 | 2.4 | 2.9 | 2.9 | 6.1 | 6.1 | 4.2 | · | · | |
| P / Cash Flow | 12.5 | 17.1 | 17.8 | 16.9 | 26.9 | 17.6 | 29.4 | · | · | |
| P / FCF | 15.8 | 20.7 | 21.3 | 20.0 | 30.5 | 18.8 | 34.4 | · | · | |
| EV / EBITDA | -46.3 | 16.7 | 29.8 | 17.8 | 33.3 | 29.6 | 27.8 | · | · | |
| EV / FCF | 23.0 | 26.2 | 28.6 | 28.4 | 38.5 | 24.1 | 50.7 | · | · | |
| EV / Revenue | 1.7 | 2.7 | 3.0 | 2.7 | 4.4 | 3.3 | 2.5 | · | · | |
| Earnings Yield | -6.8% | 4.9% | 2.1% | 4.8% | 2.0% | 0.32% | -4.6% | · | · |
損益計算書
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.69B | $1.58B | $1.66B | $1.62B | $1.68B | $1.58B | $1.69B | $1.71B | $1.70B | $1.68B | $1.72B | $1.72B | $1.74B | $1.78B | $1.79B | $1.86B | |
| Cost of Revenue | $1.16B | $1.08B | $1.14B | $1.10B | $1.13B | $1.05B | $1.12B | $1.15B | $1.12B | $1.11B | $1.15B | $1.14B | $1.15B | $1.16B | $1.18B | $1.21B | |
| Gross Profit | $537M | $501M | $524M | $526M | $554M | $535M | $563M | $564M | $582M | $570M | $570M | $579M | $590M | $625M | $614M | $651M | |
| SG&A Expense | $415M | $401M | $392M | $390M | $425M | $388M | $371M | $440M | $406M | $424M | $387M | $368M | $358M | $394M | $363M | $375M | |
| Operating Income | $122M | $100M | $126M | $-649M | $129M | $147M | $638M | $125M | $176M | $146M | $183M | $210M | $72M | $231M | $252M | $276M | |
| Interest Expense | $39M | $43M | · | $44M | $43M | $42M | · | $49M | $61M | $64M | · | $72M | $73M | $74M | · | $67M | |
| Interest Income | $10M | $10M | $11M | $12M | $11M | $8M | $12M | $27M | $18M | $18M | $18M | $17M | $16M | $14M | · | · | |
| Other Non-op | $-600.0K | $-500.0K | $-1M | $4M | $-4M | $-20M | $-5M | $700.0K | $2M | $1M | $2M | $700.0K | $2M | $600.0K | $-6M | $3M | |
| Pretax Income | $81M | $56M | $81M | $-690M | $82M | $86M | $584M | $74M | $115M | $81M | $120M | $136M | $-1M | $156M | $175M | $208M | |
| Income Tax | $43M | $12M | $28M | $22M | $17M | $21M | $84M | $17M | $22M | $20M | $21M | $28M | $6M | $34M | $33M | $41M | |
| Net Income | $38M | $43M | $52M | $-712M | $65M | $64M | $500M | $58M | $93M | $60M | $98M | $108M | $-7M | $122M | $142M | $167M | |
| EPS (Basic) | $0.06 | $0.06 | $0.08 | $-1.04 | $0.09 | $0.09 | $0.74 | $0.08 | $0.14 | $0.09 | $0.15 | $0.16 | $-0.01 | $0.18 | $0.20 | $0.25 | |
| EPS (Diluted) | $0.06 | $0.06 | $0.08 | $-1.04 | $0.09 | $0.09 | $0.73 | $0.08 | $0.14 | $0.09 | $0.14 | $0.16 | $-0.01 | $0.18 | $0.20 | $0.25 | |
| Shares (Basic) | 676,200,000 | 675,700,000 | · | 681,700,000 | 681,500,000 | 681,100,000 | · | 680,300,000 | 679,400,000 | 678,100,000 | · | 676,000,000 | 675,300,000 | 674,700,000 | · | 674,100,000 | |
| Shares (Diluted) | 677,200,000 | 676,800,000 | · | 681,700,000 | 681,800,000 | 682,400,000 | · | 683,000,000 | 682,600,000 | 681,400,000 | · | 678,500,000 | 675,300,000 | 678,100,000 | · | 679,300,000 | |
| EBITDA | $122M | $100M | · | $-649M | $129M | $147M | · | $125M | $176M | $146M | · | $210M | $72M | $231M | · | $276M |
貸借対照表
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $307M | $279M | $365M | $252M | $449M | $316M | $262M | $285M | $273M | $235M | · | $237M | $236M | $295M | · | $266M | |
| Receivables | $1.14B | $1.10B | $1.07B | $1.08B | $1.15B | $1.10B | $1.03B | $1.09B | $1.13B | $1.13B | · | $1.15B | $1.22B | $1.28B | · | $1.23B | |
| Inventory | $829M | $810M | $818M | $796M | $780M | $750M | $732M | $780M | $796M | $811M | · | $850M | $890M | $904M | · | $905M | |
| Other Current Assets | $188M | $210M | $193M | $132M | $136M | $120M | $119M | $136M | $132M | $146M | · | $147M | $156M | $152M | · | $158M | |
| Current Assets | $2.46B | $2.40B | $2.45B | $2.26B | $2.51B | $2.28B | $2.15B | $2.50B | $2.33B | $2.32B | · | $2.38B | $2.50B | $2.63B | · | $2.56B | |
| PP&E (Net) | $772M | $766M | $767M | $762M | $759M | $736M | $708M | $723M | $754M | $740M | · | $698M | $698M | $736M | · | $698M | |
| PP&E (Gross) | · | · | $1.51B | · | · | · | $1.34B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $787M | $766M | $745M | $724M | $700M | $663M | $630M | $621M | $657M | $635M | · | $580M | $565M | $541M | · | $489M | |
| Goodwill | $4.94B | $4.95B | $4.99B | $4.98B | $5.76B | $5.61B | $5.54B | $5.67B | $5.66B | $5.67B | $5.72B | $5.64B | $5.69B | $5.68B | $5.65B | $5.51B | |
| Intangibles | $2.92B | $3.01B | $3.10B | $3.17B | $3.26B | $3.24B | $3.27B | $3.43B | $3.49B | $3.57B | · | $3.70B | $3.80B | $3.98B | · | $4.01B | |
| Other Non-current Assets | $412M | $442M | $396M | $406M | $391M | $368M | $360M | $420M | $368M | $368M | · | $289M | $277M | $272M | · | $245M | |
| Total Assets | $11.60B | $11.66B | $11.79B | $11.68B | $12.78B | $12.33B | $12.11B | $12.84B | $12.69B | $12.76B | · | $12.80B | $13.06B | $13.40B | · | $13.11B | |
| Accounts Payable | $743M | $736M | $742M | $692M | $709M | $680M | $663M | $674M | $657M | $573M | · | $656M | $687M | $766M | · | $769M | |
| Current Liabilities | $1.38B | $1.37B | $1.38B | $1.52B | $2.58B | $2.03B | $2.01B | $1.63B | $1.46B | $1.44B | · | $1.49B | $1.55B | $1.67B | · | $1.55B | |
| Capital Leases | · | · | $152M | · | · | · | $143M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $540M | $550M | $557M | $548M | $536M | $550M | $557M | $547M | $575M | $601M | · | $649M | $663M | $696M | · | $728M | |
| Other Non-current Liabilities | $383M | $377M | $378M | $403M | $391M | $365M | $358M | $419M | $362M | $361M | · | $271M | $269M | $300M | · | $334M | |
| Total Liabilities | $5.97B | $6.07B | $6.23B | $6.11B | $6.49B | $6.23B | $6.16B | $7.29B | $7.26B | $7.43B | · | $7.70B | $8.05B | $8.40B | · | $8.52B | |
| Long-term Debt | $3.70B | $3.82B | $3.95B | $3.86B | $4.24B | $4.11B | $4.06B | $4.92B | $5.12B | $5.32B | · | $5.63B | $5.88B | $6.06B | · | $6.19B | |
| Total Debt | $3.70B | $3.82B | · | $3.86B | $4.24B | $4.11B | · | $4.92B | $5.12B | $5.32B | · | $5.63B | $5.88B | $6.06B | · | $6.19B | |
| Retained Earnings | $1.75B | $1.72B | $1.67B | $1.62B | $2.33B | $2.27B | $2.20B | $1.70B | $1.64B | $1.55B | · | $1.39B | $1.28B | $1.29B | · | $1.03B | |
| Treasury Stock | $76M | $76M | $76M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $-55M | $-44M | $-17M | $-24M | $-10M | $-118M | $-184M | $-74M | $-107M | $-97M | · | $-111M | $-72M | $-90M | $-100M | $-212M | |
| Stockholders' Equity | $5.63B | $5.59B | $5.57B | $5.57B | $6.29B | $6.10B | $5.96B | $5.55B | $5.43B | $5.34B | $5.25B | $5.10B | $5.01B | $4.99B | $4.86B | $4.59B | |
| Liabilities + Equity | $11.60B | $11.66B | $11.79B | $11.68B | $12.78B | $12.33B | $12.11B | $12.84B | $12.69B | $12.76B | · | $12.80B | $13.06B | $13.40B | · | $13.11B | |
| Shares Outstanding | · | 682,900,000 | 682,000,000 | 681,900,000 | 681,600,000 | 681,500,000 | 680,800,000 | 680,600,000 | 679,600,000 | 679,200,000 | · | 676,300,000 | 675,700,000 | 675,100,000 | · | 674,200,000 |
キャッシュフロー
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $106M | $105M | $103M | $104M | $103M | $100M | $101M | $102M | $103M | $100M | $101M | $98M | $103M | $101M | $101M | $101M | |
| Stock-based Comp | $15M | $9M | $11M | $7M | $16M | $12M | $11M | $12M | $11M | $13M | $9M | $10M | $9M | $13M | $10M | $12M | |
| Deferred Tax | $16M | $-10M | $50M | $-12M | $-18M | $-12M | $28M | $-23M | $-35M | $-18M | $-78M | $-29M | $-38M | $-26M | $-7M | $-22M | |
| Restructuring | · | · | $2M | $2M | · | · | $500.0K | $49M | · | · | $8M | $6M | $7M | $5M | $-200.0K | $1M | |
| Operating Cash Flow | $178M | $59M | $153M | $207M | $154M | $109M | $173M | $245M | $281M | $142M | $252M | $231M | $168M | $220M | $206M | $258M | |
| CapEx | $38M | $34M | $36M | $36M | $30M | $28M | $28M | $41M | $46M | $35M | $51M | $38M | $30M | $28M | $34M | $39M | |
| Investing Cash Flow | $-37M | $-33M | $-40M | $-33M | $-29M | $-29M | $558M | $-40M | $-45M | $-34M | $-50M | $-37M | $-29M | $-27M | $-33M | $4M | |
| Debt Issued | · | · | $1.04B | $68M | $0 | $0 | $0 | $-12M | $-29M | $41M | $0 | $0 | $0 | $0 | $82M | $35M | |
| Net Debt Issued | · | $-105M | · | · | · | $-31M | · | · | · | $-169M | · | · | · | $-270M | · | · | |
| Financing Cash Flow | $-112M | $-107M | $700.0K | $-370M | $-7M | $-34M | $-755M | $-199M | $-197M | $-130M | $-184M | $-188M | $-196M | $-275M | $-82M | $-219M | |
| Net Change in Cash | $28M | $-86M | $114M | $-198M | $134M | $54M | $-46M | $14M | $38M | $-28M | $27M | $-100.0K | $-58M | $-78M | $109M | $27M | |
| Taxes Paid | $30M | $10M | $29M | $22M | $77M | $17M | $120M | $42M | $69M | $17M | $29M | $69M | $113M | $14M | $75M | $51M | |
| Free Cash Flow | · | $25M | · | · | · | $81M | · | · | · | $107M | · | · | · | $192M | · | · | |
| Levered FCF | · | $-8M | · | · | · | $50M | · | · | · | $59M | · | · | · | $134M | · | · |
収益性
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.7% | 31.7% | · | 32.4% | 32.9% | 33.8% | · | 32.9% | 34.2% | 34.0% | · | 33.6% | 33.8% | 35.1% | · | 35.0% | |
| Operating Margin | 7.2% | 6.3% | · | -40.0% | 7.6% | 9.3% | · | 7.3% | 10.3% | 8.7% | · | 12.2% | 4.1% | 13.0% | · | 14.9% | |
| Net Margin | 2.2% | 2.7% | · | -43.8% | 3.8% | 4.1% | · | 3.4% | 5.5% | 3.6% | · | 6.3% | -0.42% | 6.8% | · | 9.0% | |
| Pretax Margin | 4.8% | 3.5% | · | -42.5% | 4.9% | 5.4% | · | 4.3% | 6.7% | 4.8% | · | 7.9% | -0.07% | 8.8% | · | 11.2% | |
| EBITDA Margin | 7.2% | 6.3% | · | -40.0% | 7.6% | 9.3% | · | 7.3% | 10.3% | 8.7% | · | 12.2% | 4.1% | 13.0% | · | 14.9% | |
| ROA | 0.31% | 0.36% | · | -5.8% | 0.51% | 0.51% | · | 0.45% | 0.72% | 0.46% | · | 0.84% | -0.06% | 0.89% | · | 1.3% | |
| ROE | 0.64% | 0.74% | · | -12.8% | 1.1% | 1.1% | · | 1.1% | 1.8% | 1.2% | · | 2.2% | -0.15% | 2.6% | · | 3.8% | |
| ROIC | 0.61% | 0.83% | · | -7.1% | 0.97% | 1.1% | · | 0.92% | 1.4% | 1.0% | · | 1.6% | 3.7% | 1.6% | · | 2.1% |
流動性と支払能力
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.8 | · | 1.5 | 1.0 | 1.1 | · | 1.5 | 1.6 | 1.6 | · | 1.6 | 1.6 | 1.6 | · | 1.6 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.6 | 0.7 | · | 0.8 | 1.0 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.5 | 0.5 | · | 0.8 | 0.9 | 0.9 | · | 1.0 | 1.1 | 1.1 | · | 1.3 | |
| Interest Coverage | 3.1 | 2.3 | · | -14.7 | 3.0 | 3.5 | · | 2.6 | 2.9 | 2.3 | · | 2.9 | 1.0 | 3.1 | · | 4.1 |
効率性
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.4 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.5 |
1株あたり
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $8.18 | · | $8.17 | $9.22 | $8.95 | · | $8.16 | $8.00 | $7.86 | · | $7.54 | $7.42 | $7.40 | · | $6.81 | |
| Revenue / Share | $2.50 | $2.34 | · | $2.38 | $2.47 | $2.32 | · | $2.51 | $2.49 | $2.47 | · | $2.54 | $2.58 | $2.63 | · | $2.73 | |
| Cash Flow / Share | · | $0.09 | · | · | · | $0.16 | · | · | · | $0.21 | · | · | · | $0.32 | · | · | |
| Cash / Share | · | $0.41 | · | $0.37 | $0.66 | $0.46 | · | $0.42 | $0.40 | $0.35 | · | $0.35 | $0.35 | $0.44 | · | $0.39 | |
| EPS (TTM) | $-0.84 | $-0.81 | · | $-0.13 | $0.99 | $1.04 | · | $0.45 | $0.53 | $0.38 | · | $0.53 | $0.62 | $0.91 | · | $0.93 |
バリュエーション（TTM）
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.56B | $6.55B | · | $6.58B | $6.67B | $6.69B | · | $6.82B | $6.83B | $6.87B | · | $7.04B | $7.18B | $7.34B | · | $7.62B | |
| Net Income TTM | $-578M | $-551M | · | $-82M | $687M | $716M | · | $310M | $360M | $260M | · | $364M | $423M | $618M | · | $639M | |
| Market Cap | · | $5.35B | · | $8.51B | $9.17B | $11.05B | · | $17.61B | $14.41B | $17.37B | · | $14.26B | $13.88B | $14.27B | · | $13.21B | |
| Enterprise Value | · | $8.89B | · | $12.12B | $12.97B | $14.84B | · | $22.24B | $19.25B | $22.46B | · | $19.65B | $19.53B | $20.04B | · | $19.14B | |
| P/E | -11.8 | -9.7 | · | -96.0 | 13.6 | 15.6 | · | 57.5 | 40.0 | 67.3 | · | 39.8 | 33.1 | 23.2 | · | 21.1 | |
| P/S | · | 0.8 | · | 1.3 | 1.4 | 1.7 | · | 2.6 | 2.1 | 2.5 | · | 2.0 | 1.9 | 1.9 | · | 1.7 | |
| P/B | · | 1.0 | · | 1.5 | 1.5 | 1.8 | · | 3.2 | 2.7 | 3.3 | · | 2.8 | 2.8 | 2.9 | · | 2.9 | |
| P / Cash Flow | · | 91.2 | · | · | · | 101.1 | · | · | · | 122.6 | · | · | · | 65.0 | · | · | |
| EV / Revenue | · | 1.4 | · | 1.8 | 1.9 | 2.2 | · | 3.3 | 2.8 | 3.3 | · | 2.8 | 2.7 | 2.7 | · | 2.5 | |
| Earnings Yield | -8.5% | -10.3% | · | -1.0% | 7.4% | 6.4% | · | 1.7% | 2.5% | 1.5% | · | 2.5% | 3.0% | 4.3% | · | 4.7% |
最新期間は左側 · null値は・として表示
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
| 指標 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 収益 | $6.55B | $6.78B | $6.97B | $7.51B | $7.39B |
| 粗利益率 % | 32.6% | 33.6% | 33.9% | 34.6% | 33.9% |
| 営業利益率 % | -3.8% | 16.0% | 10.0% | 15.0% | 13.2% |
| 純利益 | $-530M | $712M | $321M | $686M | $573M |
| 希薄化後EPS | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 |
| 指標 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 負債資本倍率 | 0.7 | 0.7 | 1.1 | 1.3 | 1.7 |
| 流動比率 | 1.8 | 1.1 | 1.6 | 1.6 | 1.7 |
| クイックレシオ | 1.0 | 0.6 | 1.0 | 1.0 | 1.1 |
| 指標 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $495M | $692M | $724M | $710M | $842M |
機関投資家（13F） 493 提出者 · $7.6B合計 · 時点 2026年9月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
保有者
493
保有価値
$7.6B
新規ポジション
97
解消済みポジション
60
機関投資家の動向 — Q2 2026 対 前四半期
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 97 (-7 前期比) | 60 (-11 前期比) | 192 (+31 前期比) | 113 (-15 前期比) | +24.9M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| Dodge & Cox | $1,188,207,643 | 120,020,974 | 15.59% | 株式数 |
| VANGUARD GROUP INC | $743,810,028 | 64,904,889 | 9.76% | 株式数 |
| BlackRock, Inc. | $695,784,194 | 70,281,231 | 9.13% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $310,298,175 | 31,343,250 | 4.07% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $304,948,067 | 30,802,835 | 4.00% | 株式数 |
| GREENHAVEN ASSOCIATES INC | $243,909,369 | 24,637,310 | 3.20% | 株式数 |
| STATE STREET CORP | $213,572,443 | 21,572,974 | 2.80% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $202,086,268 | 20,412,181 | 2.65% | 株式数 |
| Engine Capital Management, LP | $196,622,217 | 19,860,830 | 2.58% | 株式数 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $195,386,083 | 19,735,968 | 2.56% | 株式数 |
| New Mountain Capital, L.L.C. | $138,600,000 | 14,000,000 | 1.82% | 株式数 |
| Invesco Ltd. | $137,465,065 | 13,885,360 | 1.80% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $130,519,321 | 13,180,567 | 1.71% | 株式数 |
| MARSHALL WACE, LLP | $129,988,565 | 13,130,158 | 1.71% | 株式数 |
| AQR CAPITAL MANAGEMENT LLC | $115,112,902 | 11,627,566 | 1.51% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $108,794,506 | 10,989,344 | 1.43% | 株式数 |
| EARNEST PARTNERS LLC | $106,410,397 | 10,748,525 | 1.40% | 株式数 |
| LONDON CO OF VIRGINIA | $103,811,008 | 10,485,960 | 1.36% | 株式数 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $101,537,816 | 10,256,345 | 1.33% | 株式数 |
| D. E. Shaw & Co., Inc. | $94,758,077 | 9,571,523 | 1.24% | 株式数 |
| First Pacific Advisors, LP | $81,088,326 | 8,190,740 | 1.06% | 株式数 |
| SEI INVESTMENTS CO | $78,677,367 | 7,947,198 | 1.03% | 株式数 |
| FMR LLC | $77,670,074 | 7,845,462 | 1.02% | 株式数 |
| GENDELL JEFFREY L | $75,311,973 | 7,607,270 | 0.99% | 株式数 |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | $73,188,967 | 7,392,825 | 0.96% | 株式数 |
| Clarkston Capital Partners, LLC | $67,214,209 | 6,789,314 | 0.88% | 株式数 |
| MORGAN STANLEY | $66,905,804 | 6,758,161 | 0.88% | 株式数 |
| GOLDMAN SACHS GROUP INC | $61,422,976 | 6,204,341 | 0.81% | 株式数 |
| NORGES BANK | $60,307,949 | 6,091,712 | 0.79% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $57,627,950 | 5,821,005 | 0.76% | 株式数 |
| NORTHERN TRUST CORP | $56,753,512 | 5,732,678 | 0.74% | 株式数 |
| Freestone Grove Partners LP | $56,577,352 | 5,714,884 | 0.74% | 株式数 |
| UBS Group AG | $56,155,742 | 5,672,297 | 0.74% | 株式数 |
| AMERIPRISE FINANCIAL INC | $54,696,928 | 5,524,942 | 0.72% | 株式数 |
| YACKTMAN ASSET MANAGEMENT LP | $47,223,000 | 4,770,000 | 0.62% | 株式数 |
| SOUTHEASTERN ASSET MANAGEMENT INC/TN/ | $46,782,232 | 4,725,478 | 0.61% | 株式数 |
| Brickwood Asset Management LLP | $45,515,438 | 4,597,519 | 0.60% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $42,790,226 | 4,322,245 | 0.56% | 株式数 |
| JONES FINANCIAL COMPANIES LLLP | $42,363,659 | 4,120,981 | 0.56% | 株式数 |
| Bank of New York Mellon Corp | $40,800,098 | 4,121,222 | 0.54% | 株式数 |
| ROYCE & ASSOCIATES LP | $36,393,232 | 3,676,084 | 0.48% | 株式数 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $34,719,001 | 3,506,970 | 0.46% | 株式数 |
| PRIVATE MANAGEMENT GROUP INC | $30,662,617 | 3,097,234 | 0.40% | 株式数 |
| Voss Capital, LP | $26,235,000 | 2,650,000 | 0.34% | 株式数 |
| Prescott General Partners LLC | $25,740,000 | 2,600,000 | 0.34% | 株式数 |
| Gotham Asset Management, LLC | $24,912,796 | 2,516,444 | 0.33% | 株式数 |
| Quantinno Capital Management LP | $24,177,175 | 2,442,138 | 0.32% | 株式数 |
| KINNEY ASSET MANAGEMENT, LLC | $23,025,600 | 1,845,000 | 0.30% | 株式数 |
| Loews Corp | $21,780,000 | 2,200,000 | 0.29% | 株式数 |
| Western Standard LLC | $20,888,842 | 2,109,984 | 0.27% | 株式数 |
アクティビストおよび5%超のオーナー 1保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図（アクティビストの保有、取締役会キャンペーン、M&A）を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| The Goldman Sachs Group, Inc., Goldman Sachs & Co. LLC, Broad Street Principal Investments, L.L.C., Bridge Street Opportunity Advisors, L.L.C., StoneBridge 2017, L.P., StoneBridge 2017 Offshore, L.P., StoneBridge 2018, L.P., StoneBridge 2018 Offshore, L.P., VWR Partners, L.P. ×8 提出書類 | 2021年5月7日 | · | 初回提出 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
企業インサイダー 47 人のインサイダー · 29人の役員 · 20人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Emmanuel Ligner | President and CEO | 2026年8月18日 F | 737,334 | 1 | 0 | $993,125 |
| Michael Stubblefield | President & CEO | 2025年5月21日 G | 545,500 | 0 | 0 | $0 |
| Todd W. Garner | EVP and CFO | 2026年9月21日 A | 49,688 | 0 | 0 | $0 |
| Brent R. Jones | EVP, Chief Financial Officer | 2026年2月23日 F | 419,782 | 0 | 0 | $0 |
| Thomas A Szlosek | EVP & CFO | 2023年5月17日 F | 77,489 | 0 | 0 | $0 |
| Corey Walker | President, VWR Dist. & Servs. | 2026年6月21日 F | 384,535 | 0 | 0 | $0 |
| Mary Blenn | EVP, Chief Operating Officer | 2026年2月19日 A | 253,384 | 0 | 0 | $0 |
| Bjorn Hofman | EVP and COO | 2019年5月21日 A | 157,143 | 0 | 0 | $0 |
| Brittany Hankamer | EVP, Chief HR Officer | 2026年8月14日 F | 248,864 | 0 | 0 | $0 |
| Steven W Eck | SVP & Chief Accounting Officer | 2026年7月31日 F | 129,593 | 0 | 0 | $0 |
| Claudius Sokenu | EVP, Chief Legal & Compliance | 2026年7月24日 F | 251,228 | 0 | 0 | $0 |
| Ludovic Brellier | EVP, Bioscience & Medtech | 2026年5月1日 A | 146,566 | 0 | 0 | $0 |
| Benoit Gourdier | EVP, Bioscience & Medtech | 2026年2月23日 F | 362,859 | 0 | 0 | $0 |
| Christophe Couturier | EVP, AMEA | 2025年8月8日 A | 211,271 | 0 | 0 | $0 |
| James Bramwell | EVP Sales, Customer Excellence | 2025年2月27日 S | 86,605 | 0 | 0 | $0 |
| Kitty Sahin | EVP, Strategy&Corp Development | 2024年7月18日 F | 42,274 | 0 | 0 | $0 |
| Randy Lee Stone | EVP, Laboratory Solutions | 2024年4月16日 F | 68,105 | 0 | 0 | $0 |
| Sheri Lewis | EVP, Global Ops & Supply Chain | 2023年12月31日 F | 70,692 | 0 | 0 | $0 |
| Frederic Vanderhaegen | EVP, Americas and Europe | 2023年8月25日 S | 160,735 | 0 | 0 | $0 |
| Justin Miller | EVP & General Counsel | 2023年5月17日 F | 93,336 | 0 | 0 | $0 |
| Gerard Brophy | EVP, Biopharma Production | 2023年5月17日 F | 89,032 | 0 | 0 | $0 |
| Meghan Henson | EVP, Chief HR Officer | 2023年2月24日 A | 40,184 | 0 | 0 | $0 |
| Michael Wondrasch | EVP & CIO | 2023年2月20日 F | 96,072 | 0 | 0 | $0 |
| Mark Christopher Murray | EVP, Biomaterials & AT | 2022年1月13日 F | 18,680 | 0 | 0 | $0 |
| Devashish Ohri | EVP, IMEA | 2021年5月27日 M | 139,095 | 0 | 0 | $0 |
| Sven Henrichwark | EVP, APAC Region | 2021年2月25日 A | 19,802 | 0 | 0 | $0 |
| Eric Mcallister | EVP, CHRO | 2020年5月17日 F | 197,899 | 0 | 0 | $0 |
| Tanya Foxe | EVP, Operations & Supply Chain | 2020年2月21日 A | 39,458 | 0 | 0 | $0 |
| Ashish Kulkarni | EVP and Chief Technology Officer | 2019年5月21日 A | 128,571 | 0 | 0 | $0 |
| Gregory T Lucier | 取締役 | 2026年5月8日 P | 60,000 | 2 | 0 | $541,200 |
| Simon Dingemans | 取締役 | 2026年5月7日 A | 31,495 | 1 | 0 | $203,500 |
| Louise Makin | 取締役 | 2026年5月7日 A | 47,140 | 0 | 0 | $0 |
| Mala Murthy | 取締役 | 2026年5月7日 A | 69,479 | 0 | 0 | $0 |
| Michael Severino | 取締役 | 2026年5月7日 A | 85,821 | 0 | 0 | $0 |
| Joseph R Massaro | 取締役 | 2026年5月7日 A | 77,408 | 0 | 0 | $0 |
| Gregory L Summe | 取締役 | 2026年5月7日 A | 83,381 | 2 | 0 | $2,065,000 |
| Sanjeev K Mehra | 取締役 | 2026年5月7日 A | 33,376 | 2 | 0 | $4,882,750 |
| John Carethers | 取締役 | 2025年5月8日 A | 45,858 | 0 | 0 | $0 |
| Lan Kang | 取締役 | 2025年5月8日 A | 52,315 | 0 | 0 | $0 |
| Juan Andres | 取締役 | 2025年5月8日 A | 65,480 | 0 | 0 | $0 |
| Jonathan M Peacock | 取締役 | 2025年5月8日 A | 219,815 | 0 | 0 | $0 |
| Christi Shaw | 取締役 | 2023年5月11日 A | 36,271 | 0 | 0 | $0 |
| Matthew S. Holt | 取締役 | 2022年5月12日 A | 7,908 | 0 | 0 | $0 |
| Rajiv Gupta | 取締役 | 2022年4月1日 A | 780,562 | 0 | 0 | $0 |
| Jo Natauri | 取締役 | 2021年7月12日 P | 557,656 | 0 | 0 | $0 |
| Rakesh Sachdev | 取締役 | 2021年2月25日 A | 32,841 | 0 | 0 | $0 |
| Thomas Connolly | 取締役 | 2020年6月18日 S | 72,620,082 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
ETF保有状況 56のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| LSEQ · Harbor ETF Trust | 2.52% | 27,960 NS | 2026年7月31日 | N-PORT |
| EPSB · Harbor ETF Trust | 1.77% | 6,133 NS | 2026年7月31日 | N-PORT |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 1.51% | 11,851,000 | 2026年10月2日 | 日次 |
| DFSV · Dimensional ETF Trust | 0.52% | 3,118,943 NS | 2026年7月31日 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.40% | 25,471 NS | 2026年7月31日 | N-PORT |
| IVOV · VANGUARD ADMIRAL FUNDS | 0.39% | 586,296 SH | 2026年8月19日 | 日次 |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0.32% | 88,836 SH | 2026年10月2日 | 日次 |
| RWK · Invesco Exchange-Traded Fund Trust … | 0.27% | 230,747 SH | 2026年10月2日 | 日次 |
| VFVA · VANGUARD WELLINGTON FUND | 0.27% | 233,604 SH | 2026年8月19日 | 日次 |
| PTMC · Pacer Funds Trust | 0.27% | 75,616 NS | 2026年7月31日 | N-PORT |
| NUSC · Nushares ETF Trust | 0.20% | 188,520 NS | 2026年7月31日 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.20% | 10,027 NS | 2026年7月31日 | N-PORT |
| ESML · iShares Trust | 0.20% | 376,218 SH | 2026年9月11日 | 日次 |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.19% | 286,321 NS | 2026年7月31日 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.19% | 1,104,592 SH | 2026年8月19日 | 日次 |
| DFAT · Dimensional ETF Trust | 0.17% | 1,765,932 NS | 2026年7月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.17% | 1,854,609 NS | 2026年7月31日 | N-PORT |
| IYH · iShares Trust | 0.16% | 386,410 SH | 2026年9月11日 | 日次 |
| VBR · VANGUARD INDEX FUNDS | 0.14% | 9,920,672 SH | 2026年8月19日 | 日次 |
| SMMD · iShares Trust | 0.14% | 351,599 SH | 2026年9月11日 | 日次 |
| FHLC · FIDELITY COVINGTON TRUST | 0.13% | 313,238 NS | 2026年7月31日 | N-PORT |
| REVS · Columbia ETF Trust I | 0.12% | 28,653 NS | 2026年7月31日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.10% | 1,983,361 SH | 2026年8月19日 | 日次 |
| IWS · iShares Trust | 0.10% | 978,878 SH | 2026年9月11日 | 日次 |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 50,803 SH | 2026年10月2日 | 日次 |
| WSML · iShares Trust | 0.09% | 41,659 SH | 2026年9月11日 | 日次 |
| VXF · VANGUARD INDEX FUNDS | 0.08% | 7,835,858 SH | 2026年8月19日 | 日次 |
| VB · VANGUARD INDEX FUNDS | 0.08% | 15,636,784 SH | 2026年8月19日 | 日次 |
| TILT · FlexShares Trust | 0.08% | 121,976 NS | 2026年7月31日 | N-PORT |
| RECS · Columbia ETF Trust I | 0.08% | 325,274 NS | 2026年7月31日 | N-PORT |
| IWR · iShares Trust | 0.07% | 2,700,866 SH | 2026年9月11日 | 日次 |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.06% | 37,709 SH | 2026年10月2日 | 日次 |
| PRF · Invesco Exchange-Traded Fund Trust | 0.04% | 251,941 SH | 2026年10月2日 | 日次 |
| IUSV · iShares Trust | 0.03% | 593,664 SH | 2026年9月11日 | 日次 |
| DXUV · Dimensional ETF Trust | 0.03% | 11,452 NS | 2026年7月31日 | N-PORT |
| IWD · iShares Trust | 0.03% | 1,462,438 SH | 2026年9月11日 | 日次 |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 397,791 SH | 2026年8月19日 | 日次 |
| IYY · iShares Trust | 0.01% | 29,349 SH | 2026年9月11日 | 日次 |
| IWB · iShares Trust | 0.01% | 457,613 SH | 2026年9月11日 | 日次 |
| ITOT · iShares Trust | 0.01% | 885,606 SH | 2026年9月11日 | 日次 |
| IWV · iShares Trust | 0.01% | 183,968 SH | 2026年9月11日 | 日次 |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 21,681,946 SH | 2026年8月19日 | 日次 |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 534,809 SH | 2026年8月19日 | 日次 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 109,164 SH | 2026年8月19日 | 日次 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 55,632 SH | 2026年8月19日 | 日次 |
| ESGV · VANGUARD WORLD FUND | 0.01% | 149,286 SH | 2026年8月19日 | 日次 |
| NEAR · iShares U.S. ETF Trust | 0.01% | 365,000 SH | 2026年9月9日 | 日次 |
| DFUS · Dimensional ETF Trust | 0.00% | 5,257 NS | 2026年7月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 544 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 1,476 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 2,958 NS | 2026年7月31日 | N-PORT |
| IJH · iShares Trust | · | 23,957,709 SH | 2026年9月11日 | 日次 |
| IJJ · iShares Trust | · | 3,487,441 SH | 2026年8月31日 | 日次 |
| XJH · iShares Trust | · | 93,400 SH | 2026年9月8日 | 日次 |
| ISCB · iShares Trust | · | 29,420 SH | 2026年9月11日 | 日次 |
| ISCV · iShares Trust | · | 144,718 SH | 2026年9月11日 | 日次 |
AVTR アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
レーティング · 25 アナリスト
保有
中央値ターゲット
$14.20
-7.4%
3 12.0%
強い買い
5 20.0%
買い
16 64.0%
保有
1 4.0%
売り
0 0.0%
強い売り
12ヶ月目標株価
14 アナリスト · 2026-10-05平均値ターゲット $14.56 -5.1%
現在
現在価格 $15.34
安値$12.00
平均値$14.56
高値$19.00
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
FY基準、価格は各社の直近年度末終値。
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| AVTR | $7.82B | -14.7 | -3.4% | -8.1% | -8.9% | 32.6% |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| TEM | · | -41.9 | 83.4% | -19.3% | -61.2% | · |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | · |
| TXG | $2.08B | -46.6 | 5.2% | -6.8% | -5.5% | 69.0% |
| TECH | $11.03B | 60.9 | -0.38% | 15.0% | 9.0% | 65.8% |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | · |
| BRKR | $7.17B | -314.1 | 2.1% | -0.25% | -0.40% | 45.9% |
| BIO | · | · | · | · | · | · |
| SHC | $5.02B | 65.3 | 5.7% | 6.7% | 14.0% | 55.5% |
| ADPT | $2.50B | -41.6 | 54.8% | -21.5% | -28.2% | · |
最新ニュース この会社に言及した最近の見出し
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
重視する指標を選択してください — 上記の「財務諸表」の任意の行の横にある「+」をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
出典：SEC 10-Q 提出日 7月 29, 2026